Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

LIPPINCOTT WILLIAMS & WILKINS

1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1 AI069412, UM1 AI069423, UM1 AI069432, UM1 AI069452, UM1 AI069465, UM1 AI106701]
2. UNC-CH CFAR [P30 AI50410]
3. NCATS [UL1TR001111]
4. Gilead Sciences
5. ViiV Healthcare
6. Gilead
7. Janssen
8. GlaxoSmithKline
9. Merck
10. ViiV